Scalable automation for cell and gene therapy

DNA / RNA

Scalable automation for cell and gene therapy

02 Mar, 2026

Celltrio advances automated life science workflows with a modular platform supporting allogeneic and autologous cell and gene therapy from research through GMP manufacturing. Built on a common automation backbone, RoboCell™ configurations adapt to specific culture formats, process requirements, and regulatory environments.

RoboCell Mito™ delivers compact automation for T-flask culturing, while RoboCell GMP™ extends the same architecture into GMP-aligned environments for controlled, documented manufacturing. RoboCell Suspension™ supports TubeSpin® and Erlenmeyer flasks, integrating automated handling, shaking incubation, and environmental control for scalable suspension cell expansion.

RoboStor™ complements the platform with automated vapour-phase LN₂ biobanking. Its Mini-Cryo-Chamber enables controlled-rate freezing and individual cryovial handling while maintaining sample temperatures at approximately -135°C to preserve cryogenic integrity.

Together, Celltrio delivers configurable, scalable automation aligned to biology, workflow complexity, and compliance requirements.

More information online

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Measurement to mitigation in the next evolution of emissions monitoring
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow